俞玲芳, 王利明, 赵瑞珩. 组织microRNA-124表达及HPV18病毒载量与宫颈癌发病的相关性[J]. 解放军医学院学报, 2018, 39(7): 598-601. DOI: 10.3969/j.issn.2095-5227.2018.07.013
引用本文: 俞玲芳, 王利明, 赵瑞珩. 组织microRNA-124表达及HPV18病毒载量与宫颈癌发病的相关性[J]. 解放军医学院学报, 2018, 39(7): 598-601. DOI: 10.3969/j.issn.2095-5227.2018.07.013
YU Lingfang, WANG Liming, ZHAO Ruiheng. Correlation of microRNA-124 expression and high risk HPV18 viral load in cervical cancer[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2018, 39(7): 598-601. DOI: 10.3969/j.issn.2095-5227.2018.07.013
Citation: YU Lingfang, WANG Liming, ZHAO Ruiheng. Correlation of microRNA-124 expression and high risk HPV18 viral load in cervical cancer[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2018, 39(7): 598-601. DOI: 10.3969/j.issn.2095-5227.2018.07.013

组织microRNA-124表达及HPV18病毒载量与宫颈癌发病的相关性

Correlation of microRNA-124 expression and high risk HPV18 viral load in cervical cancer

  • 摘要: 目的 探讨组织中高危型HPV病毒的载量和microRNA-124表达水平与宫颈癌发病的相关性,为宫颈癌的临床监测以及诊断提供依据。 方法 选取在2013年9月- 2016年9月在我院行宫颈活检的宫颈癌变患者205例,其中正常或炎症56例,宫颈上皮内瘤变Ⅰ级(cervical intraepithelial neoplasia gradeⅠ,CINⅠ)32例,宫颈上皮内瘤变Ⅱ级(CINⅡ)37例,宫颈上皮内瘤变Ⅲ级(CINⅢ)31例,宫颈癌49例(宫颈鳞癌38例,宫颈腺癌11例)。对宫颈组织或细胞采用逆转录—荧光定量PCR检测microRNA-124的相对表达,采用第二代杂交捕获技术(HCⅡ)检测HPV18病毒的载量,病毒载量1 pg/ml为阴性组,1 ~ 50 pg/ml为低级载量组,51 ~ 500 pg/ml为中级载量组,501 ~ 1 000 pg/ml则为高级载量组,1 001 pg/ml及以上为极高病毒载量组。Spearman相关性分析病毒载量与宫颈组织病变程度的相关性。 结果 宫颈癌组HPV18病毒载量及microRNA-124表达水平显著高于其他组(P均< 0.05),而正常或炎症组高危型HPV病毒载量及microRNA-124的表达水平最低(P=0.001),并且随着宫颈癌病变加重,HPV病毒载量及microRNA-124的表达水平也随之升高;Spearman相关分析显示,高危型HPV病毒载量与宫颈病变程度呈正相关(R=0.975,P=0.000);随着宫颈癌病变加重,microRNA-124表达水平呈线性升高(R=0.889,P=0.012)。 结论 宫颈组织中microRNA-124表达水平及高危型HPV病毒载量与宫颈癌的发生密切相关。

     

    Abstract: Objective To explore the correlation of microRNA-124 expression and high risk HPV viral load with cervical cancer so as to provide evidence for clinical monitoring and diagnosis. Methods A total of 205 patients who suffered from cervical lesions and received cervical biopsies in our hospital from September 2013 to September 2016 were included in the study. Fifty-six patients were healthy or with inf l ammation, 32 patients with cervical intraepithelial neoplasia gradeⅠ(CINⅠ), 37 patients with gradeⅡ(CINⅡ)and 31 patients with gradeⅢ(CINⅢ). Forty-nine patients had cervical cancer (38 cases of squamous and 11 cases of adenocarcinoma). Reverse transcription-f l uorescence quantitative PCR and hybrid captureⅡ(HCⅡ) were used to detect the relative expression of microRNA-124 and HPV18 virus load. According to the virus load, we categorized the patients into negative group (≤ 1 pg/ml), low-load group (1-50 pg/ml), medium-load group (51-500 pg/ml) and high-load group (501-1 000 pg/ml).The relationship between high risk of HPV viral load and degree of cervical tissue lesion was analyzed by Spearman analysis. Results The HPV18 virus load and level of microRNA-124 in cervical cancer patients were significantly higher than those in other groups (all P< 0.05), while they were the lowest in the healthy and inf l ammation group (P=0.001). The HPV virus load and expression level of microRNA-124 increased with the aggravation of cervical cancer. The high-risk HPV virus load was positively correlated with occurrence of cervical cancer (R=0.974, P=0.000). The expression of microRNA-124 linearly increased with grading of cervical lesions (R=0.889, P=0.012). Conclusion The expression level of microRNA-124 in tissues and high risk HPV virus load are closely related to cervical cancer.

     

/

返回文章
返回